Gefapixant, a P2X3 receptor antagonist, for the treatment...

  • Main
  • 2020 / 08
  • Gefapixant, a P2X3 receptor antagonist, for the treatment...

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: A randomized, double-blind, controlled, parallel-group, Phase 2b trial: Discussions from a Twitter journal club @respandsleepjc (#rsjc)

Kawala, Christopher, Anand, Anju, Stanbrook, Matthew
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
DOI:
10.1080/24745332.2020.1777598
Date:
August, 2020
File:
PDF, 687 KB
2020
Conversion to is in progress
Conversion to is failed